A clinical trial of a drug treating Alzheimer's was successful. What does that mean for patients? Published October 5, 2022 at 1:52 PM EDT Facebook Twitter LinkedIn Email Listen • 5:50 A woman, suffering from Alzheimer's desease, holds the hand of a relative on March 18, 2011 in a retirement house in Angervilliers, eastern France. (Sebastien Bozon/AFP via Getty Images) Here & Now‘s Scott Tong speaks with STAT’s biotech reporter Damian Garde about a promising study of a drug that could reduce the cognitive effects of Alzheimer’s disease. This article was originally published on WBUR.org. Copyright 2022 NPR. To see more, visit https://www.npr.org.